Structure

Physi-Chem Properties

Molecular Weight:  378.15
Volume:  392.361
LogP:  5.482
LogD:  3.893
LogS:  -3.395
# Rotatable Bonds:  3
TPSA:  79.9
# H-Bond Aceptor:  5
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.479
Synthetic Accessibility Score:  3.611
Fsp3:  0.261
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.863
MDCK Permeability:  1.574983798491303e-05
Pgp-inhibitor:  0.616
Pgp-substrate:  0.01
Human Intestinal Absorption (HIA):  0.032
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.068

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.018
Plasma Protein Binding (PPB):  88.23002624511719%
Volume Distribution (VD):  0.698
Pgp-substrate:  10.475132942199707%

ADMET: Metabolism

CYP1A2-inhibitor:  0.931
CYP1A2-substrate:  0.209
CYP2C19-inhibitor:  0.87
CYP2C19-substrate:  0.099
CYP2C9-inhibitor:  0.816
CYP2C9-substrate:  0.855
CYP2D6-inhibitor:  0.756
CYP2D6-substrate:  0.162
CYP3A4-inhibitor:  0.56
CYP3A4-substrate:  0.128

ADMET: Excretion

Clearance (CL):  6.592
Half-life (T1/2):  0.2

ADMET: Toxicity

hERG Blockers:  0.01
Human Hepatotoxicity (H-HT):  0.973
Drug-inuced Liver Injury (DILI):  0.983
AMES Toxicity:  0.601
Rat Oral Acute Toxicity:  0.441
Maximum Recommended Daily Dose:  0.617
Skin Sensitization:  0.65
Carcinogencity:  0.891
Eye Corrosion:  0.004
Eye Irritation:  0.254
Respiratory Toxicity:  0.733

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474681

Natural Product ID:  NPC474681
Common Name*:   6,11-Dihydroxy-3-Methyl-3-(4-Methylpent-3-Enyl)Pyrano[2,3-C]Xanthen-7-One
IUPAC Name:   6,11-dihydroxy-3-methyl-3-(4-methylpent-3-enyl)pyrano[2,3-c]xanthen-7-one
Synonyms:  
Standard InCHIKey:  LVANTWLBTIEHSX-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C23H22O5/c1-13(2)6-5-10-23(3)11-9-14-18(28-23)12-17(25)19-20(26)15-7-4-8-16(24)21(15)27-22(14)19/h4,6-9,11-12,24-25H,5,10H2,1-3H3
SMILES:  CC(=CCCC1(C)C=Cc2c(O1)cc(c1c2oc2c(O)cccc2c1=O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL479289
PubChem CID:   5465516
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones
                • [CHEMONTID:0003521] Pyranoxanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO5638 Garcinia livingstonei Species Clusiaceae Eukaryota n.a. fruit n.a. DOI[10.1016/S0040-4020(01)89039-6]
NPO5638 Garcinia livingstonei Species Clusiaceae Eukaryota root bark n.a. n.a. PMID[16562837]
NPO5638 Garcinia livingstonei Species Clusiaceae Eukaryota n.a. fruit n.a. PMID[21028890]
NPO5638 Garcinia livingstonei Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT171 Cell Line MRC5 Homo sapiens IC50 > 64000.0 nM PMID[475254]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei IC50 = 5000.0 nM PMID[475254]
NPT580 Organism Trypanosoma cruzi Trypanosoma cruzi IC50 = 8000.0 nM PMID[475254]
NPT1021 Organism Leishmania infantum Leishmania infantum IC50 > 64000.0 nM PMID[475254]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 = 52000.0 nM PMID[475254]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474681 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC218313
0.9933 High Similarity NPC133970
0.9933 High Similarity NPC5322
0.9933 High Similarity NPC204879
0.9933 High Similarity NPC6633
0.9866 High Similarity NPC472280
0.9866 High Similarity NPC200246
0.9803 High Similarity NPC167678
0.9803 High Similarity NPC29876
0.9803 High Similarity NPC234644
0.98 High Similarity NPC470600
0.98 High Similarity NPC472455
0.9799 High Similarity NPC273462
0.9799 High Similarity NPC33051
0.9799 High Similarity NPC227337
0.9799 High Similarity NPC49402
0.9799 High Similarity NPC70433
0.9739 High Similarity NPC472448
0.9739 High Similarity NPC83922
0.9737 High Similarity NPC188433
0.9737 High Similarity NPC204290
0.9737 High Similarity NPC471973
0.9735 High Similarity NPC52889
0.9733 High Similarity NPC117992
0.9733 High Similarity NPC256925
0.9733 High Similarity NPC234255
0.9733 High Similarity NPC168247
0.9733 High Similarity NPC152951
0.9733 High Similarity NPC230149
0.9733 High Similarity NPC57674
0.9732 High Similarity NPC237994
0.9673 High Similarity NPC57715
0.9673 High Similarity NPC259456
0.9671 High Similarity NPC74178
0.9671 High Similarity NPC184755
0.9669 High Similarity NPC471985
0.9664 High Similarity NPC154345
0.961 High Similarity NPC474162
0.961 High Similarity NPC474150
0.9608 High Similarity NPC476980
0.9608 High Similarity NPC118256
0.9608 High Similarity NPC192686
0.9608 High Similarity NPC119209
0.9605 High Similarity NPC136674
0.9605 High Similarity NPC304008
0.9605 High Similarity NPC187745
0.9605 High Similarity NPC161960
0.9548 High Similarity NPC303460
0.9548 High Similarity NPC23298
0.9548 High Similarity NPC306321
0.9548 High Similarity NPC189473
0.9545 High Similarity NPC134783
0.9545 High Similarity NPC474038
0.9539 High Similarity NPC138243
0.9539 High Similarity NPC282307
0.9539 High Similarity NPC191146
0.9539 High Similarity NPC115853
0.9539 High Similarity NPC170026
0.9539 High Similarity NPC68093
0.9536 High Similarity NPC170492
0.9487 High Similarity NPC275780
0.9487 High Similarity NPC239752
0.9487 High Similarity NPC472450
0.9484 High Similarity NPC474034
0.9484 High Similarity NPC474033
0.9484 High Similarity NPC329760
0.9484 High Similarity NPC261470
0.9481 High Similarity NPC475784
0.9481 High Similarity NPC474960
0.9477 High Similarity NPC36852
0.9477 High Similarity NPC78225
0.9477 High Similarity NPC219867
0.9477 High Similarity NPC473272
0.9477 High Similarity NPC291508
0.9477 High Similarity NPC262286
0.9477 High Similarity NPC476981
0.9477 High Similarity NPC284820
0.9477 High Similarity NPC27337
0.9477 High Similarity NPC180011
0.947 High Similarity NPC477231
0.947 High Similarity NPC39732
0.947 High Similarity NPC471982
0.947 High Similarity NPC60972
0.947 High Similarity NPC257648
0.9467 High Similarity NPC88804
0.9467 High Similarity NPC29231
0.9467 High Similarity NPC3825
0.9463 High Similarity NPC272721
0.9463 High Similarity NPC196277
0.9463 High Similarity NPC43669
0.943 High Similarity NPC288813
0.9427 High Similarity NPC39091
0.9427 High Similarity NPC472449
0.9427 High Similarity NPC37870
0.9423 High Similarity NPC124038
0.9423 High Similarity NPC186686
0.9423 High Similarity NPC472625
0.9419 High Similarity NPC472632
0.9419 High Similarity NPC471210
0.9419 High Similarity NPC26326
0.9419 High Similarity NPC258331
0.9416 High Similarity NPC235448
0.9412 High Similarity NPC276444
0.9412 High Similarity NPC195796
0.9412 High Similarity NPC291878
0.9412 High Similarity NPC472907
0.9412 High Similarity NPC35038
0.9412 High Similarity NPC278778
0.9408 High Similarity NPC472905
0.9404 High Similarity NPC256406
0.9404 High Similarity NPC31363
0.9396 High Similarity NPC168803
0.9396 High Similarity NPC77378
0.9363 High Similarity NPC303174
0.9363 High Similarity NPC300053
0.9363 High Similarity NPC108433
0.9363 High Similarity NPC50960
0.9363 High Similarity NPC62261
0.9359 High Similarity NPC476247
0.9359 High Similarity NPC25152
0.9359 High Similarity NPC229632
0.9359 High Similarity NPC78332
0.9355 High Similarity NPC174953
0.9355 High Similarity NPC328102
0.9355 High Similarity NPC28241
0.9355 High Similarity NPC139036
0.9355 High Similarity NPC472624
0.9351 High Similarity NPC78071
0.9351 High Similarity NPC237418
0.9351 High Similarity NPC299520
0.9351 High Similarity NPC474055
0.9351 High Similarity NPC471209
0.9351 High Similarity NPC67876
0.9351 High Similarity NPC129684
0.9351 High Similarity NPC472598
0.9351 High Similarity NPC476630
0.9351 High Similarity NPC218871
0.9351 High Similarity NPC472963
0.9346 High Similarity NPC470327
0.9346 High Similarity NPC113906
0.9346 High Similarity NPC477503
0.9346 High Similarity NPC256612
0.9346 High Similarity NPC45849
0.9346 High Similarity NPC200761
0.9346 High Similarity NPC20830
0.9342 High Similarity NPC157784
0.9342 High Similarity NPC63187
0.9342 High Similarity NPC37684
0.9342 High Similarity NPC472912
0.9338 High Similarity NPC472279
0.9304 High Similarity NPC235610
0.9304 High Similarity NPC43319
0.9299 High Similarity NPC187491
0.9299 High Similarity NPC236521
0.9299 High Similarity NPC319200
0.9299 High Similarity NPC248638
0.9299 High Similarity NPC152659
0.9299 High Similarity NPC207690
0.9295 High Similarity NPC472634
0.9295 High Similarity NPC61010
0.9295 High Similarity NPC471212
0.9295 High Similarity NPC472906
0.9295 High Similarity NPC471211
0.9295 High Similarity NPC266314
0.929 High Similarity NPC474290
0.929 High Similarity NPC55738
0.929 High Similarity NPC473990
0.929 High Similarity NPC100123
0.929 High Similarity NPC250214
0.929 High Similarity NPC172770
0.929 High Similarity NPC187792
0.929 High Similarity NPC95936
0.929 High Similarity NPC185258
0.929 High Similarity NPC117418
0.929 High Similarity NPC53545
0.9286 High Similarity NPC472626
0.9286 High Similarity NPC474638
0.9286 High Similarity NPC209614
0.9286 High Similarity NPC472916
0.9286 High Similarity NPC470328
0.9286 High Similarity NPC265511
0.9281 High Similarity NPC255350
0.9281 High Similarity NPC176775
0.9281 High Similarity NPC88645
0.9281 High Similarity NPC160951
0.9281 High Similarity NPC271779
0.9281 High Similarity NPC206238
0.9281 High Similarity NPC231018
0.9281 High Similarity NPC47781
0.9281 High Similarity NPC18727
0.9281 High Similarity NPC213896
0.9281 High Similarity NPC69394
0.9281 High Similarity NPC274327
0.9281 High Similarity NPC145379
0.9281 High Similarity NPC22519
0.9281 High Similarity NPC167091
0.9281 High Similarity NPC469550
0.9281 High Similarity NPC192083
0.9281 High Similarity NPC292214
0.9281 High Similarity NPC74924

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474681 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9281 High Similarity NPD2393 Clinical (unspecified phase)
0.9281 High Similarity NPD2801 Approved
0.9216 High Similarity NPD1934 Approved
0.9067 High Similarity NPD1511 Approved
0.9038 High Similarity NPD3882 Suspended
0.8947 High Similarity NPD1512 Approved
0.8882 High Similarity NPD6166 Phase 2
0.8882 High Similarity NPD6167 Clinical (unspecified phase)
0.8882 High Similarity NPD6168 Clinical (unspecified phase)
0.8882 High Similarity NPD7410 Clinical (unspecified phase)
0.8839 High Similarity NPD4380 Phase 2
0.8773 High Similarity NPD3818 Discontinued
0.8758 High Similarity NPD4378 Clinical (unspecified phase)
0.875 High Similarity NPD5494 Approved
0.872 High Similarity NPD7054 Approved
0.8679 High Similarity NPD4868 Clinical (unspecified phase)
0.8667 High Similarity NPD7074 Phase 3
0.8667 High Similarity NPD7472 Approved
0.8625 High Similarity NPD7075 Discontinued
0.8616 High Similarity NPD3817 Phase 2
0.8553 High Similarity NPD7096 Clinical (unspecified phase)
0.8512 High Similarity NPD4338 Clinical (unspecified phase)
0.8509 High Similarity NPD4381 Clinical (unspecified phase)
0.8503 High Similarity NPD6797 Phase 2
0.8487 Intermediate Similarity NPD1549 Phase 2
0.8452 Intermediate Similarity NPD7251 Discontinued
0.8438 Intermediate Similarity NPD7819 Suspended
0.8438 Intermediate Similarity NPD1465 Phase 2
0.8428 Intermediate Similarity NPD7411 Suspended
0.8421 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8421 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8415 Intermediate Similarity NPD6232 Discontinued
0.8411 Intermediate Similarity NPD1510 Phase 2
0.8402 Intermediate Similarity NPD7808 Phase 3
0.8389 Intermediate Similarity NPD943 Approved
0.8385 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8375 Intermediate Similarity NPD6801 Discontinued
0.8373 Intermediate Similarity NPD7473 Discontinued
0.8355 Intermediate Similarity NPD2796 Approved
0.8274 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8274 Intermediate Similarity NPD5844 Phase 1
0.8267 Intermediate Similarity NPD1240 Approved
0.8217 Intermediate Similarity NPD6799 Approved
0.8176 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8171 Intermediate Similarity NPD3749 Approved
0.8158 Intermediate Similarity NPD1607 Approved
0.8141 Intermediate Similarity NPD3750 Approved
0.8133 Intermediate Similarity NPD6959 Discontinued
0.8133 Intermediate Similarity NPD1247 Approved
0.8121 Intermediate Similarity NPD919 Approved
0.8095 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD5402 Approved
0.8036 Intermediate Similarity NPD3926 Phase 2
0.8025 Intermediate Similarity NPD6599 Discontinued
0.8023 Intermediate Similarity NPD6559 Discontinued
0.8 Intermediate Similarity NPD7768 Phase 2
0.8 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD2800 Approved
0.795 Intermediate Similarity NPD5403 Approved
0.7933 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7885 Intermediate Similarity NPD2935 Discontinued
0.7857 Intermediate Similarity NPD447 Suspended
0.7848 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7848 Intermediate Similarity NPD1243 Approved
0.784 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD5401 Approved
0.7821 Intermediate Similarity NPD2799 Discontinued
0.7821 Intermediate Similarity NPD3748 Approved
0.7821 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7814 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7792 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7792 Intermediate Similarity NPD1613 Approved
0.7778 Intermediate Similarity NPD2313 Discontinued
0.7771 Intermediate Similarity NPD6099 Approved
0.7771 Intermediate Similarity NPD6100 Approved
0.7744 Intermediate Similarity NPD3226 Approved
0.7742 Intermediate Similarity NPD230 Phase 1
0.773 Intermediate Similarity NPD920 Approved
0.7722 Intermediate Similarity NPD2344 Approved
0.7722 Intermediate Similarity NPD2346 Discontinued
0.7716 Intermediate Similarity NPD2534 Approved
0.7716 Intermediate Similarity NPD2533 Approved
0.7716 Intermediate Similarity NPD2532 Approved
0.7709 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7658 Intermediate Similarity NPD1551 Phase 2
0.7657 Intermediate Similarity NPD5953 Discontinued
0.764 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD1933 Approved
0.7624 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7597 Intermediate Similarity NPD3027 Phase 3
0.7593 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD3751 Discontinued
0.7582 Intermediate Similarity NPD9494 Approved
0.758 Intermediate Similarity NPD6651 Approved
0.7578 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD4628 Phase 3
0.7571 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7548 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7548 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD7390 Discontinued
0.7546 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7543 Intermediate Similarity NPD7286 Phase 2
0.7531 Intermediate Similarity NPD2309 Approved
0.7514 Intermediate Similarity NPD7685 Pre-registration
0.75 Intermediate Similarity NPD7199 Phase 2
0.7485 Intermediate Similarity NPD6234 Discontinued
0.7484 Intermediate Similarity NPD4625 Phase 3
0.747 Intermediate Similarity NPD1653 Approved
0.7459 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7457 Intermediate Similarity NPD3787 Discontinued
0.7451 Intermediate Similarity NPD1203 Approved
0.743 Intermediate Similarity NPD8312 Approved
0.743 Intermediate Similarity NPD8313 Approved
0.7423 Intermediate Similarity NPD6190 Approved
0.7419 Intermediate Similarity NPD4908 Phase 1
0.7414 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7403 Intermediate Similarity NPD2798 Approved
0.7386 Intermediate Similarity NPD7228 Approved
0.7382 Intermediate Similarity NPD7584 Approved
0.7375 Intermediate Similarity NPD4308 Phase 3
0.7351 Intermediate Similarity NPD4360 Phase 2
0.7351 Intermediate Similarity NPD4363 Phase 3
0.734 Intermediate Similarity NPD6777 Approved
0.734 Intermediate Similarity NPD6779 Approved
0.734 Intermediate Similarity NPD6776 Approved
0.734 Intermediate Similarity NPD6781 Approved
0.734 Intermediate Similarity NPD6780 Approved
0.734 Intermediate Similarity NPD6782 Approved
0.734 Intermediate Similarity NPD6778 Approved
0.7325 Intermediate Similarity NPD3268 Approved
0.7308 Intermediate Similarity NPD8150 Discontinued
0.7303 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD5124 Phase 1
0.7296 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD37 Approved
0.7289 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD4965 Approved
0.7267 Intermediate Similarity NPD7033 Discontinued
0.7267 Intermediate Similarity NPD4967 Phase 2
0.7267 Intermediate Similarity NPD4966 Approved
0.7257 Intermediate Similarity NPD5711 Approved
0.7257 Intermediate Similarity NPD5710 Approved
0.7255 Intermediate Similarity NPD9269 Phase 2
0.7255 Intermediate Similarity NPD9717 Approved
0.7228 Intermediate Similarity NPD4287 Approved
0.7226 Intermediate Similarity NPD2797 Approved
0.7226 Intermediate Similarity NPD1470 Approved
0.7225 Intermediate Similarity NPD7435 Discontinued
0.7222 Intermediate Similarity NPD5405 Approved
0.7222 Intermediate Similarity NPD5404 Approved
0.7222 Intermediate Similarity NPD5406 Approved
0.7222 Intermediate Similarity NPD5408 Approved
0.7219 Intermediate Similarity NPD7458 Discontinued
0.7219 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD8151 Discontinued
0.7216 Intermediate Similarity NPD5242 Approved
0.7213 Intermediate Similarity NPD8434 Phase 2
0.7209 Intermediate Similarity NPD4288 Approved
0.7208 Intermediate Similarity NPD4749 Approved
0.7197 Intermediate Similarity NPD6832 Phase 2
0.7193 Intermediate Similarity NPD6844 Discontinued
0.719 Intermediate Similarity NPD422 Phase 1
0.719 Intermediate Similarity NPD1610 Phase 2
0.7186 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7176 Intermediate Similarity NPD6585 Discontinued
0.7161 Intermediate Similarity NPD3225 Approved
0.7152 Intermediate Similarity NPD1548 Phase 1
0.7143 Intermediate Similarity NPD1608 Approved
0.7143 Intermediate Similarity NPD5049 Phase 3
0.7135 Intermediate Similarity NPD7696 Phase 3
0.7135 Intermediate Similarity NPD7698 Approved
0.7135 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7697 Approved
0.7134 Intermediate Similarity NPD2424 Discontinued
0.7128 Intermediate Similarity NPD4361 Phase 2
0.7128 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD4357 Discontinued
0.7125 Intermediate Similarity NPD4307 Phase 2
0.711 Intermediate Similarity NPD5353 Approved
0.7108 Intermediate Similarity NPD2354 Approved
0.7107 Intermediate Similarity NPD411 Approved
0.7107 Intermediate Similarity NPD3764 Approved
0.7098 Intermediate Similarity NPD7870 Phase 2
0.7098 Intermediate Similarity NPD7871 Phase 2
0.7088 Intermediate Similarity NPD7549 Discontinued
0.7086 Intermediate Similarity NPD5536 Phase 2
0.7083 Intermediate Similarity NPD6823 Phase 2
0.7081 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD2403 Approved
0.7078 Intermediate Similarity NPD1201 Approved
0.7077 Intermediate Similarity NPD7701 Phase 2
0.7074 Intermediate Similarity NPD6534 Approved
0.7074 Intermediate Similarity NPD6535 Approved
0.7073 Intermediate Similarity NPD1471 Phase 3
0.7062 Intermediate Similarity NPD7229 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data